Label: ESUNIX ORAL BACTERIOSTATIC LIQUID- cetylpyridinium chloride liquid

  • NDC Code(s): 87118-005-01, 87118-005-02
  • Packager: Xiling (Zhenjiang) Medical Technology Co., Ltd.
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated September 27, 2025

If you are a consumer or patient please visit this version.

View All Sections
  • ACTIVE INGREDIENT

    Cetylpyridinium chloride 0.05% (w/w)

  • PURPOSE

    Oral antiseptic

  • DOSAGE & ADMINISTRATION

    Adults and children 6 years and older:
    Use after brushing. Tear open one pouch and pour into mouth. Gargle for 20 seconds, then spit out. Do not rinse with water.

    Children under 6 years:
    Use only under the supervision of a dentist or physician.

  • WARNINGS

    For oral use only. Do not swallow.

    Accidental ingestion of small amounts is not expected to cause harm.

    Avoid contact with eyes. If contact occurs, rinse thoroughly with water.

    Stop use and ask a doctor if irritation or allergic reaction occurs.

    Keep out of reach of children. If more than used for rinsing is swallowed, get medical help or contact a Poison Control Center right away.

  • INDICATIONS & USAGE

    Helps reduce bacteria in the mouth that may cause bad breath and oral discomfort.

  • INACTIVE INGREDIENT

    Purified water, Sorbitol, PEG-40 hydrogenated castor oil, Glycerin, Propylparaben, Fragrance, Sodium benzoate, Lonicera japonica flower extract, Prunus speciosa flower extract, Glycyrrhiza uralensis extract, Camellia sinensis polyphenols, Sodium citrate, Menthol, Sucralose.

  • KEEP OUT OF REACH OF CHILDREN

    keep out of reach of children section

  • PRINCIPAL DISPLAY PANEL

    1

  • INGREDIENTS AND APPEARANCE
    ESUNIX ORAL BACTERIOSTATIC LIQUID 
    cetylpyridinium chloride liquid
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:87118-005
    Route of AdministrationDENTAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    CETYLPYRIDINIUM CHLORIDE (UNII: D9OM4SK49P) (CETYLPYRIDINIUM - UNII:CUB7JI0JV3) CETYLPYRIDINIUM CHLORIDE0.05 mg  in 100 mg
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM BENZOATE (UNII: OJ245FE5EU)  
    SORBITOL (UNII: 506T60A25R)  
    CAMELLIA SINENSIS LEAF (UNII: W2ZU1RY8B0)  
    MENTHOL (UNII: L7T10EIP3A)  
    GLYCYRRHIZA URALENSIS (UNII: 42B5YD8F0K)  
    SODIUM CITRATE (UNII: 1Q73Q2JULR)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    FRAGRANCE MINT ORC2000774 (UNII: G7LK3FFB99)  
    LONICERA JAPONICA FLOWER (UNII: 4465L2WS4Y)  
    PEG-40 HYDROGENATED CASTOR OIL (UNII: 7YC686GQ8F)  
    SUCRALOSE (UNII: 96K6UQ3ZD4)  
    PRUNUS SPECIOSA FLOWER (UNII: A78OOO9299)  
    WATER (UNII: 059QF0KO0R)  
    PROPYLPARABEN (UNII: Z8IX2SC1OH)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:87118-005-021 in 1 BOX09/21/2025
    1NDC:87118-005-0112 mg in 1 BOX, UNIT-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM02209/21/2025
    Labeler - Xiling (Zhenjiang) Medical Technology Co., Ltd. (707119039)
    Registrant - Xiling (Zhenjiang) Medical Technology Co., Ltd. (707119039)
    Establishment
    NameAddressID/FEIBusiness Operations
    Xiling (Zhenjiang) Medical Technology Co., Ltd.707119039manufacture(87118-005)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!